These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 14624709)

  • 1. Integration of targeted therapies in gemcitabine chemotherapy regimens.
    Blumenschein GR; Herbst RS
    Clin Lung Cancer; 2003 Jan; 4(4):217-23. PubMed ID: 14624709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted therapy using novel agents in the treatment of non-small-cell lung cancer.
    Herbst RS
    Clin Lung Cancer; 2002 Mar; 3 Suppl 1():S30-8. PubMed ID: 14720353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of the unresectable non small cell lung carcinoma].
    Spásová I
    Cas Lek Cesk; 2005; 144(9):602-12; discussion 612-3. PubMed ID: 16193938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging drugs for non-small cell lung cancer.
    Cappuzzo F; Bartolini S; Crinò L
    Expert Opin Emerg Drugs; 2003 May; 8(1):179-92. PubMed ID: 14610920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy regimens in advanced non-small-cell lung cancer: recent randomized trials.
    Belani CP
    Clin Lung Cancer; 2002 Mar; 3 Suppl 1():S5-9. PubMed ID: 14720348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging role of epidermal growth factor receptor inhibition in therapy for advanced malignancy: focus on NSCLC.
    Langer CJ
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):991-1002. PubMed ID: 14967461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of targeted therapy in non-small cell lung cancer: hype or hope?
    Langer CJ
    Expert Rev Anticancer Ther; 2003 Aug; 3(4):443-55. PubMed ID: 12934657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gemcitabine in the first line therapy of advanced and metastatic non-small-cell lung carcinoma (NSCLC): review of the results of phase III studies].
    Langer F; Helsberg K; Schütte WH; Leschinger MI
    Onkologie; 2005 Mar; 28 Suppl 1():1-28. PubMed ID: 15802886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted therapies for non-small cell lung cancer.
    Dempke WC; Suto T; Reck M
    Lung Cancer; 2010 Mar; 67(3):257-74. PubMed ID: 19914732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted therapy in non-small cell lung cancer.
    Giaccone G
    Lung Cancer; 2002 Nov; 38 Suppl 2():S29-32. PubMed ID: 12431826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer: A Review.
    Arbour KC; Riely GJ
    JAMA; 2019 Aug; 322(8):764-774. PubMed ID: 31454018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical treatment of advanced non-small cell lung cancer in elderly patients: a review of the role of chemotherapy and targeted agents.
    Meoni G; Cecere FL; Lucherini E; Di Costanzo F
    J Geriatr Oncol; 2013 Jul; 4(3):282-90. PubMed ID: 24070465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New molecular targeted therapies integrated with radiation therapy in lung cancer.
    Provencio M; Sánchez A; Garrido P; Valcárcel F
    Clin Lung Cancer; 2010 Mar; 11(2):91-7. PubMed ID: 20199974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenesis inhibitors and vascular disrupting agents in non-small cell lung cancer.
    Rossi A; Maione P; Ferrara ML; Sacco PC; Schettino C; Bareschino MA; Gridelli C
    Curr Med Chem; 2009; 16(30):3919-30. PubMed ID: 19747132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing chemotherapy and targeted agent combinations in NSCLC.
    Lynch T; Kim E
    Lung Cancer; 2005 Dec; 50 Suppl 2():S25-32. PubMed ID: 16557671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted therapy in advanced gastric carcinoma: the future is beginning.
    Schinzari G; Cassano A; Orlandi A; Basso M; Barone C
    Curr Med Chem; 2014; 21(8):1026-38. PubMed ID: 24304282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy and chemotherapy in locally advanced non-small cell lung cancer: preclinical and early clinical data.
    Reboul FL
    Hematol Oncol Clin North Am; 2004 Feb; 18(1):41-53. PubMed ID: 15005280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nimotuzumab combined with gemcitabine and cisplatin as second-line chemotherapy for advanced non-small-cell lung cancer.
    Wang HQ; Ren Y; Qian ZZ; Fu K; Zhang HL; Li W; Hou Y; Zhou SY; Hao XS; Xie CH
    Thorac Cancer; 2012 Feb; 3(1):72-78. PubMed ID: 28920255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.